google.com
Flux RSS de Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr
Reçois les dernières mises à jour de Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr dès leur publication.
Derniers articles
Retrouvez Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr là où vous lisez
Les personnes qui suivent Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr suivent également
-
Search Feed scrip.pharmaintelligence.informa.com
-
Google Alert - "tocilizumab biosimilar" google.co.uk
-
-
ClinicalTrials.gov: adalimumab | Last update posted in the last 14 days clinicaltrials.gov
-
ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days clinicaltrials.gov
-
-
investors.pfizer.com investors.pfizer.com
-
Investor Update roche.com
Questions
Quelle est l’URL du flux RSS de Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr ?
L’adresse du flux est https://www.google.com/alerts/feeds/11317382618987300685/7968218245088029816. Collez-la dans n’importe quel lecteur RSS ou cliquez sur Suivre maintenant pour le lire dans Feeder.
À quelle fréquence Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr publie-t-il ?
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr publie environ 3 fois par jour. La dernière publication remonte à environ 4 heures.
Le flux RSS de Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr fonctionne-t-il ?
Oui. Feeder l’a vérifié il y a 9 minutes et le flux a répondu normalement.
Comment suivre Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr dans Feeder ?
Cliquez sur Suivre maintenant et inscrivez-vous si vous n’avez pas encore de compte. L’offre gratuite de Feeder permet de suivre jusqu’à 200 flux sur le Web, iPhone et Android. Aucune carte bancaire requise.
Suivez Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr dans Feeder
L’offre gratuite de Feeder permet de suivre jusqu’à 200 flux sur le Web, iPhone et Android. Aucune carte bancaire requise.